Literature DB >> 25381941

Endothelial and metabolic disorders in adolescence: low birth weight is not an isolated risk factor.

Priscila de Jesus dos Santos Alves, Ana Ciléia P T Henriques, Livia R M Pinto, Rosa Maria S Mota, Carlos Henrique M Alencar, Renata S Alves, Francisco Herlânio C Carvalho.   

Abstract

BACKGROUND: Low birth weight (LBW) seems to be a determining factor for many cardiovascular diseases in adult life.
OBJECTIVES: The objectives of this study were to investigate the occurrence of metabolic syndrome (MetS) and endothelial dysfunction in adolescents with LBW and compare them with subjects with normal birth weights (NBW).
METHODS: This retrospective cohort study evaluated 172 adolescents (86 in each group) aged 10-20 years, who were born in a reference maternity hospital. The following criteria were adopted: International Diabetes Federation parameters for the diagnosis of MetS and flow-mediated brachial artery dilatation for endothelial dysfunction. Student's t-test or Mann-Whitney tests were used for continuous variables (depending on the normality of distribution evaluated by the Shapiro-Wilk test), and the Fisher exact test was used for categorical variables. The significance level was determined at 0.05.
RESULTS: MetS was present in three cases of LBW and in four cases of NBW (p=0.70). The number of components of the syndrome was, on average, 0.6 and 0.5 in LBW and NBW, respectively (p=0.77). Endothelial dysfunction occurred in 25 (29.1%) cases of LBW and in 31 (36.1%) cases of NBW (p=0.33).
CONCLUSION: LBW did not represent a risk factor in the occurrence of MetS or endothelial dysfunction in adolescence.

Entities:  

Mesh:

Year:  2015        PMID: 25381941     DOI: 10.1515/jpem-2014-0146

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  1 in total

1.  Glycemic variability predicts inflammation in adolescents with type 1 diabetes.

Authors:  Robert P Hoffman; Amanda S Dye; Hong Huang; John A Bauer
Journal:  J Pediatr Endocrinol Metab       Date:  2016-10-01       Impact factor: 1.634

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.